Mount Lucas Management LP Amgen Inc Transaction History

Mount Lucas Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $19,022 - $23,617	-87 Reduced 0.85%	10,168 $2.73 Million
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $292,907 - $346,356	-1,367 Reduced 11.76%	10,255 $2.28 Million
Q1 2023 May 12, 2023	BUY	$225.79 - $275.2 $130,732 - $159,340	579 Added 5.24%	11,622 $2.81 Million
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $2.53 Million - $3.21 Million	11,043 New	11,043 $2.9 Million

3,121

407M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Mount Lucas Management LP, based on Form 13F filings with the SEC.

Stay updated on Mount Lucas Management LP with notifications on news.